Bristol-Myers公司推出家用HbA1c检测设备

一种家庭用检测糖化血红蛋白的测试为糖尿病患者自己检测血糖立刻提供结果。这项检测项目已经获得了美国药品食品管理局的许可。

这项检测项目叫做ChoiceDM，是一次性使用的设备，允许在家中的糖尿病患者监测疾病进程、帮助医护专家监测治疗反应。从一小滴血中只需要三个步骤就可以在八分钟之内得到检测结果。检测设备将无需医生处方即可在药店出售。这种设备是Bristol-Myers Squibb公司的产品。

A1C被推崇为远期控制血糖效果检测的标准指标。美国糖尿病学会推荐在所有糖尿病患者中每年检测四次A1C的水平。接受调整饮食或者运动疗法的患者可以检测A1C来监测疾病进程。研究显示A1C下降1％就可以降低糖尿病并发症的风险，例如眼、肾脏以及神经系统病变。美国糖尿病学会推荐糖尿病患者维持7％或者更低的A1C水平。

美国加利福尼亚大学圣地亚哥分校的医学教授Steve Edelman医生说：“这种检测不仅方便，而且鼓励患者对自己病情更关注，并激励他们主动参与糖尿病的控制。毫无疑问ChoiceDM A1C家庭检测的广泛使用将在提高糖尿病的短期以及长期治疗效果。

Disposable Home Test for HbA1c
 
A test for measuring glycated hemoglobin (HbA1c, or A1C) that provides immediate results is designed for use by diabetes patients at home. The test has been cleared by the U.S. Food and Drug Administration (FDA).

Called ChoiceDM, the disposable device allows at-home diabetes patients to track their progress and help their healthcare professionals in monitoring response to treatment. The three-step test provides results in eight minutes from a small drop of blood. The test will be sold in pharmacies without a prescription. It is the product of Bristol-Myers Squibb Company (New York, NY, USA).

A1C is the preferred standard indicator for measuring long-term blood sugar control. The American Diabetes Association recommends A1C testing on all patients with diabetes up to four times a year. Patients who are modifying their diet or exercise regimen may measure their A1C levels to track their progress. Studies have shown that a 1% reduction in A1C decreases the risk of serious complications in diabetics, such as eye, kidney, and nerve damage. The ADA recommends that diabetics maintain an A1C level of 7% or less.

“Not only is it more convenient, but it will also motivate patients to be more informed and active participants in their own diabetes management,” commented Dr. Steve Edelman, professor of medicine at the University of California, San Diego (USA). “There is no question that the widespread availability of the ChoiceDM A1C home test will improve diabetes care over the short and long term.”